Reyhan Kose Cobanoglu: APS ACTION Registry Study Published in Lupus
Reyhan Kose Cobanoglu, Assistant Professor at Adnan Menderes University School of Medicine, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Lupus, adding:
”Very happy to have been part of this APS ACTION Registry study, now published in ‘Lupus’.
The study looks at persistent single aPL positivity in primary APS and explores the important differences across antibody profiles, particularly isolated lupus anticoagulant positivity.
Definitely worth a read for anyone interested in APS – check it out!”
Title: Clinical characteristics of patients with primary antiphospholipid syndrome and ”single” antiphospholipid antibody: Retrospective results from the APS ACTION clinical database and repository (”registry”)
Authors: Silvia Grazietta Foddai, Irene Cecchi, Massimo Radin, Laura Bertolaccini, Danieli de Andrade, Maria Tektonidou, Vittorio Pengo, Chary Lopez-Pedrera, Diana Paredes-Ruiz, Howard Michael Belmont, Paul R. Fortin, Denis Wahl, Ware Branch, Maria Gerosa, Guilherme de Jesus, Zhouli Zhang, Tatsuya Atsumi, Maria Efthymiou, Laura Andreoli, Esther Rodriguez, Michelle Petri, Ricard Cervera, Bahar Artim-Esen, Rosana Quintana, Jason S. Knight, Rohan Willis, Reyhan Kose Cobanoglu, Hannah Cohen, Doruk Erkan, Savino Sciascia
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 11, 2026, 17:14Obi Light Ogbonnia: From Kenya to Global Sickle Cell Advocacy
-
Sep 11, 2026, 17:01EAHAD 2027 Marks 20 Years
-
Sep 11, 2026, 16:54Denise Braendgaard: Reimagining Health Systems Through Collective Action
-
Sep 11, 2026, 16:47Jehad Khamaysa: Budd-Chiari Syndrome as the Initial Presentation of Behçet’s Disease in a 16-Year-Old
-
Sep 11, 2026, 16:44Mostafa Faisal Mohammed Saleh: From HLA Biology to Curative Therapy
-
Sep 11, 2026, 16:38Jim Kaveney: Class I, Level A – Lifestyle is Now the Official Standard in AFib Care
-
Sep 11, 2026, 16:31George Touma: Do We Really Need to Implant Metal in Every High-Bleeding-Risk Patient?
-
Sep 11, 2026, 16:24Yonah S. Tehrani: CDT vs Anticoagulation in Intermediate High Risk PE – The PRAGUE-26 Trial
-
Sep 11, 2026, 16:09Elad Anter։ A New Map of Atrial Fibrillation Initiation